Goldman Sachs Group Inc Alx Oncology Holdings Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 256,879 shares of ALXO stock, worth $416,143. This represents 0.0% of its overall portfolio holdings.

Number of Shares
256,879
Previous 215,252 19.34%
Holding current value
$416,143
Previous $1.3 Million 63.99%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.81 - $8.13 $75,344 - $338,427
41,627 Added 19.34%
256,879 $467,000
Q2 2024

Aug 13, 2024
BUY
$5.84 - $17.56 $340,180 - $1.02 Million
58,250 Added 37.1%
215,252 $1.3 Million
Q1 2024

May 15, 2024
BUY
$10.95 - $16.79 $725,536 - $1.11 Million
66,259 Added 73.02%
157,002 $1.75 Million
Q4 2023

Feb 13, 2024
SELL
$4.81 - $15.38 $194,247 - $621,105
-40,384 Reduced 30.8%
90,743 $1.35 Million
Q3 2023

May 14, 2024
BUY
$4.19 - $7.35 $169,208 - $296,822
40,384 Added 44.5%
131,127 $629,000
Q3 2023

Nov 14, 2023
SELL
$4.19 - $7.35 $203,801 - $357,504
-48,640 Reduced 27.06%
131,127 $629,000
Q2 2023

May 14, 2024
SELL
$4.37 - $9.56 $3,845 - $8,412
-880 Reduced 0.49%
179,767 $1.35 Million
Q2 2023

Aug 14, 2023
SELL
$4.37 - $9.56 $3,845 - $8,412
-880 Reduced 0.49%
179,767 $1.35 Million
Q1 2023

May 14, 2024
BUY
$4.52 - $11.71 $23,440 - $60,728
5,186 Added 2.96%
180,647 $816,000
Q1 2023

May 11, 2023
BUY
$4.52 - $11.71 $23,440 - $60,728
5,186 Added 2.96%
180,647 $816,000
Q4 2022

May 14, 2024
BUY
$9.51 - $12.95 $139,939 - $190,559
14,715 Added 9.15%
175,461 $1.98 Million
Q4 2022

Feb 13, 2023
BUY
$9.51 - $12.95 $139,939 - $190,559
14,715 Added 9.15%
175,461 $1.98 Million
Q3 2022

May 14, 2024
SELL
$8.23 - $15.14 $715,985 - $1.32 Million
-86,997 Reduced 35.12%
160,746 $1.54 Million
Q3 2022

Nov 10, 2022
SELL
$8.23 - $15.14 $715,985 - $1.32 Million
-86,997 Reduced 35.12%
160,746 $1.54 Million
Q2 2022

May 14, 2024
BUY
$5.89 - $19.46 $924,730 - $3.06 Million
157,000 Added 173.02%
247,743 $2 Million
Q2 2022

Aug 15, 2022
BUY
$5.89 - $19.46 $195,883 - $647,181
33,257 Added 15.51%
247,743 $2 Million
Q1 2022

May 16, 2022
BUY
$13.65 - $22.06 $1.03 Million - $1.66 Million
75,348 Added 54.15%
214,486 $3.63 Million
Q4 2021

Feb 14, 2022
SELL
$21.49 - $74.4 $512,708 - $1.78 Million
-23,858 Reduced 14.64%
139,138 $2.99 Million
Q3 2021

Nov 10, 2021
BUY
$52.51 - $80.91 $8.56 Million - $13.2 Million
162,996 New
162,996 $12 Million

Others Institutions Holding ALXO

# of Institutions
101
Shares Held
39.7M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $66M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email